Persistent URL of this record https://hdl.handle.net/1887/99123
In Collections
This item can be found in the following collections:
High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups on the Value of High Dose AraC
- All authors
- Willemze, R.; Suciu, S.; Mandelli, F.; Meloni, G.; Labar, B.; Halkes, S.J.M.; Muus, P.; Mistrik, M.; Specchia, G.; Fabbiano, F.; Nobile, F.; Sborgia, M.; Camera, A.; Selleslag, D.; Lefrere, F.; Magro, D.; Leone, G.; Cantore, N.; Beksac, M.; Berneman, Z.; Thomas, X.; Melillo, L.; Bron, D.; Fillet, G.; Guimaraes, J.E.; Amadori, S.; Fazi, P.; Karrasch, M.; Vignetti, M.; Witte, T. de; Marie, J.P.
- Date
- 2011-11-18
- Journal
- Blood
- Volume
- 118
- Issue
- 21
- Pages
- 117 - 118